Track Panacea Biotec Limited — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

Panacea Biotec Limited PANACEABIO.NS · Stock Open Panacea Biotec Limited in new tab

397.95 INR
EPS
-1.18
P/B
3.16
Beta
0.14
Loading chart...
Key Metrics
EPS-1.18
Book Value128.44
Price to Book3.16
Debt/Equity2.79
% Insiders72.652%
Growth
Revenue Growth0.01%
Earnings Growth-0.12%

DCF Valuation

Tweak assumptions to recompute fair value for Panacea Biotec Limited (PANACEABIO.NS)
Currency: INR
DCF Assumptions
Decimal (e.g., 0.10 = 10%). Range allows declines (−50%) to strong growth (+50%).
Decimal (e.g., 0.30 = 30%).
Decimal (e.g., 0.04 = 4%).
Decimal (e.g., 0.20 = 20%).
Percent number (e.g., 3 = 3%).
Percent number (e.g., 10 = 10%).
Percent number (e.g., 5 = 5%).
DCF Result

Fair Value (DCF)
—
Current Price
—
Upside
—
WACC
—
Terminal PV
—
Σ PV of FCFs
—
Note: historical bars show reported FCF (for context); forward bars show PV of projected FCF; if no per-year data, totals are shown.

Panacea Biotec Limited Logo Panacea Biotec Limited Analysis (PANACEABIO.NS)

India Health Care Official Website Stock

Is Panacea Biotec Limited a good investment? Panacea Biotec Limited (PANACEABIO.NS) is currently trading at 397.95 INR.

Investor FAQ

Does Panacea Biotec Limited pay a dividend?

No, it does not currently pay a dividend.

What asset class is Panacea Biotec Limited?

Panacea Biotec Limited is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.

Company Profile

Panacea Biotec Limited, a biotechnology company, engages in the research, development, manufacture, and marketing of vaccines, pharmaceutical formulations, nutraceuticals, and food and nutrition products in India and internationally. It operates through Vaccines and Pharmaceutical formulations & Nutrition segments. The company's product portfolio includes prescription products in various therapeutic areas, such as oncology, diabetes, gastro-intestinal care, nephrology, orthopedics, pain management, and fever; cold and cough; and betacoronavirus, SARS-CoV-2, typhoid conjugate, pneumococcal conjugate, tetravalent dengue, Mpox, and hepatitis A vaccines, etc. It also offers health supplement products; and paediatric nutrition products under the ChilRunFull, ChilRun 7+, and ChillRun No Sucrose brands. In addition, the company engages in the real estate business. It exports its products to approximately 50 countries. The company has collaboration agreements with the Russian Direct Investment Fund for producing Covid-19 vaccine, and Sputnik-V; and the Indian Council of Medical Research for clinical trials of DengiAll vaccine. Panacea Biotec Limited was incorporated in 1984 and is based in New Delhi, India.

Exchange Ticker
NSI (India) PANACEABIO.NS
Trades
Dividend History paid per year (INR)
Historical Dividends
Year Total Dividends
▸2011
0.75 INR
Oct. 10, 2011 0.7500
▸2010
0.25 INR
Oct. 25, 2010 0.2500
▸2008
1.00 INR
Oct. 26, 2008 1.0000
▸2007
1.00 INR
Oct. 28, 2007 1.0000
▸2006
1.00 INR
Oct. 11, 2006 1.0000
▸2005
1.50 INR
Sept. 1, 2005 1.5000
▸2004
1.00 INR
Oct. 17, 2004 1.0000
▸2003
1.00 INR
Oct. 1, 2003 1.0000
▸2002
10.00 INR
Sept. 3, 2002 10.0000
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Fundamentals

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion